Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (3)
  • Open Access

    ARTICLE

    miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein

    Feng Shuai*, Bo Wang, Shuxiao Dong

    Oncology Research, Vol.26, No.7, pp. 1113-1121, 2018, DOI:10.3727/096504018X15166199939341

    Abstract miR-522-3p is known to degrade bloom syndrome protein (BLM) and enhance expression of other proto-oncogenes, leading to tumorigenesis. This study aimed to investigate the molecular mechanisms of miR-522-3p in human colorectal cancer (CRC) cells. Expressions of miR-522-3p in CRC and adjacent tissues, as well as in normal human colon epithelial cell line (FHC) and five CRC cell lines, were detected. Human CRC cell lines, HCT-116 and HT29, were transfected with miR-522-3p mimic, inhibitor, or scrambled controls. Then cell viability, apoptosis, cell cycle progression, and the expressions of c-myc, cyclin E, CDK2, and BLM were assessed.… More >

  • Open Access

    ARTICLE

    Plasma concentrations of angiopoietin-1, angiopoietin-2 and Tie-2 in colon cancer

    Hüseyin Engin1, Yücel Üstündağ2, İshak Özel Tekin3, Ayla Gökmen4, Şehmuz Ertop4, Sevil Uygun İlikhan5

    European Cytokine Network, Vol.23, No.2, pp. 68-71, 2012, DOI:10.1684/ecn.2012.0308

    Abstract Background/Aim: despite the rapidly accumulating histopathological data reporting differences in the expression of members of the angiopoietin family on the surface of various normal and tumour cells, data for these growth factors in plasma from cancer patients, including colon cancer, are scarce. The aims of the present study were to measure the plasma concentrations of Ang-1, Ang-2 and Tie-2 in colon cancer patients, and to assess the correlation between the concentrations of these factors and the stage of the tumor. Patients and methods: the study cohort included 36 patients (18 male, 18 female) with colon… More >

  • Open Access

    ARTICLE

    Genitourinary tract preservation versus pelvic exenteration for advanced colorectal tumors

    Nicolas Muruve

    Canadian Journal of Urology, Vol.10, No.2, pp. 1815-1818, 2003

    Abstract Introduction: Total pelvic exenteration (TPE) is the standard of care for locally advanced colorectal cancer. This is a morbid procedure often leaving the patient with two ostomy sites and an extended recovery. Bladder preservation with complete tumor resection is often possible in these cases and we set out to determine if limited resection of the GU tract was as effective in tumor control as TPE.
    Materials and methods: This is a retrospective review of all patients over a 7-year period with colorectal tumors invading the urinary system. These patients were divided into two groups based upon the… More >

Displaying 1-10 on page 1 of 3. Per Page